Advanced search
Publication Cover
Brain Injury Volume 19, 2005 - Issue 4
Submit an article Journal homepage
138
Views
20
CrossRef citations to date
0
Altmetric
Pilot Study

Reduction of affective lability and alcohol use following traumatic brain injury: A clinical pilot study of anti-convulsant medications

Thomas P. Beresford Denver Veterans Affairs Medical Center (DVAMC), Denver, CO, USA; University of Colorado Health Sciences Center, Denver, CO, USACorrespondence[email protected]
,
David Arciniegas Department of Psychiatry, University of Colorado School of Medicine, Denver, CO, USA; Department of Neurology, University of Colorado School of Medicine, Denver, CO, USA; Brain Injury Rehabilitation Unit, Spalding Rehabilitation Hospital, Aurora, CO, USA
,
Lori Clapp University of Colorado Health Sciences Center, Denver, CO, USA
,
Brandon Martin University of Colorado Health Sciences Center, Denver, CO, USA
&
Julie Alfers University of Colorado Health Sciences Center, Denver, CO, USA
Pages 309-313 | Received 14 Aug 2003, Accepted 29 Apr 2004, Published online: 03 Jul 2009

References

  • Miller N. Alcohol and drug disorders. In: Silver JM, Yudofsky SC, Hales RE, editors. Neuropsychiatry of Traumatic Brain Injury. Washington DC: American Psychiatrc Press Inc.; 1994; pp 471–512.
  • Hibbard MR, Uysal S, Kepler K, et al. Axis I psychopathology in individuals with traumatic brain injury. Journal of Head Trauma Rehabilitation 1998;13:24–39.
  • Bourdon KH, Rae DS, Locke BZ, et al. Estimating the prevalence of mental disorders in US adults from the Epidemiologic Catchment Area Survey. Public Health Reports 1992;107:663–8.
  • Schneider U, Altmann A, Baumann M, et al. Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: The first Multicentre Study in Germany. Alcohol & Alcoholism 2001;36:219–23.
  • Longo LP, Campbell T, Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. Journal of Addictive Diseases 2002;21:55–64.
  • Brady KT, Myrick H, Henderson S, et al. The use of divalproex in alcohol relapse prevention: A pilot study. Drug & Alcohol Dependence 2002;67:323–30.
  • Johnson BA, Ait-Daoid N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: A randomised controlled trial. [comment]. Lancet 2003;361:1677–85.
  • Arciniegas DB, Topkoff J. The neuropsychiatry of pathologic affect: An approach to evaluation and treatment. Seminars in Clinical Neuropsychiatry 2000;5:290–306.
  • Koponen S, Taiminen T, Porfin R, et al. Axis I and II psychiatric disorders after traumatic brain injury: A 30-year follow-up study. American Journal of Psychiatry 2002;159:1315–21.
  • Palmer A, Marion D, Botscheller M, et al. Increased transmitter amino acid concentration in human ventricular CSF after brain trauma. Neuroreport 1994;6:153–6.
  • O'Dell DM, Hamm RJ. Chronic post-injury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury. Journal of Neurosurgery 1995; 83:878–83.
  • Reeves TM, Lyeth BG, Phillips LL, et al. The effects of traumatic brain injury on inhibition in the hippocampus and dentate gyrus. Brain Research 1997;757:119–32.
  • Erb DE, Povlishock JT. Neuroplasticity following traumatic brain injury: A study of GABAergic terminal loss and recovery in the cat dorsal lateral vestibular nucleus. Experimental Brain Research 1991;83:253–67.
  • Petty F. GABA and mood disorders: A brief review and hypothesis. Journal of Affective Disorders 1995;34:275–81.
  • Oruc L, Verheyen GR, Furac I, et al. Positive association between the GABRA5 gene and unipolar recurrent major depression. Neuropsychobiology 1997;36:62–4.
  • Papadimitriou GN, Dikeos DG, Karadima G, et al. Association between the GABA(A) receptor alpha5 subunit gene locus (GABRA5) and bipolar affective disorder. American Journal of Medical Genetics 1998;81:73–80.
  • Perucca E. Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience. CNS Drugs 2002;16:695–714.
  • White HS. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 1999;40 (Suppl 5):52–10.
  • Kawata Y, Okada M, Murakami T, et al. Pharmacological discrimination between effects of carbamazepine on hippo-campal basal, Ca(2+)- and K(+)-evoked serotonin release. British Journal of Pharmacology 2001;133:557–67.
  • Ichikawa J, Meltzer HY. Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation. European Journal of Pharmacology 1999; 380:R1–3.
  • Corrigan JD. Substance abuse as a mediating factor in outcome from traumatic brain injury. Archives of Physical Medicine & Rehabilitation 1995;76:302–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.